• Annexin V-Cy5/DAPI Apoptosis Kit: Mechanistic Precision in L

  2026-05-22

  Explore how the Annexin V-Cy5/DAPI Apoptosis Kit enables high-precision detection of apoptosis and necrosis, with unique insights into mitochondrial pathways in leukemia. This article provides advanced scientific context and practical assay guidance for cell death analysis.

• Efficient iPSC Differentiation into Retinal Ganglion Cells v

  2026-05-21

  Chavali et al. introduce a robust, chemically defined protocol that enables efficient and reproducible differentiation of human induced pluripotent stem cells (iPSCs) into retinal ganglion cells (RGCs) by dual inhibition of SMAD and Wnt pathways. This innovation addresses longstanding challenges in variability and purity, facilitating consistent RGC generation for disease modeling and neurodegenerative research.

• Lactate-GPR81-Rac1 Signaling Enables Insulin-Independent Glu

  2026-05-21

  The reference study uncovers a novel insulin-independent pathway for glucose uptake in skeletal muscle, mediated by lactate-activated GPR81/FARP1 signaling and Rac1 activation. This mechanism highlights new therapeutic targets for hyperglycemia and informs research into Rac1 pathway inhibition and metabolic disease modulation.

• Lopinavir (ABT-378): Unveiling Serum-Resilient HIV and Coron

  2026-05-20

  Explore the unique serum-resistant potency of Lopinavir (ABT-378) in both HIV and emerging coronavirus research. This in-depth analysis integrates groundbreaking cross-viral findings and advanced assay design strategies for next-generation antiretroviral discovery.

• Morin: Applied Protocols and Innovations in Mitochondrial Re

  2026-05-20

  Morin delivers a unique combination of mitochondrial modulation and fluorescent probe utility, enabling robust assays for metabolic and neuroprotective research. This guide details workflow enhancements, protocol parameters, and troubleshooting strategies to maximize Morin’s impact in energy metabolism and disease modeling.

• FK866 (APO866): NAMPT Inhibition and Host Defense Engineerin

  2026-05-19

  Explore the dual impact of FK866 (APO866) as a NAMPT inhibitor in cancer and innate immunity research. This article unveils mechanistic insights and new application horizons beyond standard hematologic cancer models.

• Docetaxel in Oncology Research: Mechanisms, Resistance, and

  2026-05-19

  Explore the multifaceted role of Docetaxel in cancer chemotherapy research, with a focus on apoptosis induction, resistance mechanisms, and translational assay design. This article offers fresh insights into Docetaxel’s scientific applications and practical considerations in modern oncology.

• VX-661 F508del CFTR Corrector: Optimizing Rescue Workflows

  2026-05-18

  VX-661 (F508del CFTR corrector) empowers precise modulation of trafficking-deficient CFTR in cystic fibrosis research, unlocking variant-specific rescue strategies. Discover advanced workflows, data-driven troubleshooting, and novel calnexin-informed optimization for reproducible and robust CFTR rescue.

• Mechanisms of ZAK Activation at Collided Ribosomes Deciphere

  2026-05-18

  This study elucidates the mechanistic and structural basis for ZAK kinase activation during ribosome collisions, revealing how RACK1 scaffolding and SAM domain dimerization at the collision interface drive the ribotoxic stress response. These findings refine our understanding of translational quality control and have implications for kinase signaling research in cancer and stress biology.

• Mecamylamine Hydrochloride: Decoding nAChR Circuitry in Neur

  2026-05-17

  Explore the advanced mechanistic roles of Mecamylamine hydrochloride in dissecting nicotinic acetylcholine receptor pathways for neuropsychiatric disorder research. This article offers a unique, in-depth analysis bridging gut-brain axis discoveries with practical assay strategies.

• Oral Gepotidacin for Urogenital Gonorrhoea: Phase 3 Non-Infe

  2026-05-16

  The EAGLE-1 phase 3 trial demonstrates that oral gepotidacin is non-inferior to standard dual therapy for uncomplicated urogenital gonorrhoea, with high rates of microbiological cure. This work provides crucial clinical evidence for a novel oral antibiotic option amid growing antimicrobial resistance.

• VE-822 ATR Inhibitor: Mechanistic Insights and Next-Gen Assa

  2026-05-15

  Explore the molecular mechanism and practical assay optimization of VE-822, a potent ATR inhibitor. This article provides distinct, actionable insights for DNA damage response research and cancer chemoradiotherapy sensitization.

• Direct Mouse Genotyping Kit Plus: Streamlining Mouse Genetic

  2026-05-15

  Leverage the Direct Mouse Genotyping Kit Plus for rapid, purification-free mouse genotyping workflows. This kit empowers robust transgene detection, gene knockout validation, and high-throughput colony screening with exceptional ease and reliability.

• Amitriptyline HCl: Technical Guide for Experimental Use

  2026-05-14

  Amitriptyline HCl (SKU B2231) provides a well-characterized tool for researchers investigating neurotransmitter receptor modulation in neuropharmacology workflows, particularly where selectivity for serotonin, norepinephrine, 5-HT4, 5-HT2, and sigma-1 receptors is required. This compound is not suitable for workflows needing long-term solution stability or where mechanistic specificity outside its documented receptor profile is essential.

• THZ1: Covalent CDK7 Inhibitor for Advanced T-ALL Research

  2026-05-14

  THZ1 offers a unique, irreversible mechanism targeting CDK7, enabling researchers to overcome resistance in transcription regulation assays—especially for T-ALL models. This guide details practical workflows, troubleshooting insights, and the latest evidence on mutation-driven resistance, setting THZ1 apart as a critical tool in modern cancer biology.

8645 records 18/577 page Previous Next First page 上5页 1617181920 下5页 Last page